Summary of Significant Accounting Policies (Details) - Schedule of antidilutive due to the net loss - shares	3 Months Ended	6 Months Ended
Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Warrants [Member]
Equivalent common shares
Equivalent common shares	18,436	95,056	18,436	95,056
Unvested Restricted Stock Awards [Member]
Equivalent common shares
Equivalent common shares	1,185	14,644	1,185	14,644
Stock options [Member]
Equivalent common shares
Equivalent common shares	1,187,872	736,593	1,187,872	736,593

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration